What are synthetic drugs?
New, synthetic versions of harmful drugs, including synthetic opioids and synthetic cannabinoids, are increasingly found in UK’s illegal drug markets.

A Westminster Hall debate on Special educational needs and children's mental health services is scheduled for 9 February 2022 between 9:30-11:00am. Laura Farris MP will open the debate.
The House of Commons Library briefing paper on Children and young people’s mental health – policy, CAMHS services, funding and education (updated 15 June 2021) provides an overview of Department of Health and Social Care, Department for Education and NHS policy to improve mental health support for children and young people in England.
The Parliamentary Office of Science and Technology briefing on Children’s Mental Health and the COVID-19 Pandemic (published 9 September 2021) summarises the latest understanding from research about the effects on children throughout the pandemic, and the factors that increase vulnerability to poor mental health. It also reviews policy approaches that seek to protect children’s mental health.
For statistics on mental health services and funding the House of Commons Library has published the briefing Mental health statistics: prevalence, services and funding in England (updated 13 December, 2021).
The House of Commons Library briefing on Autism (published 1 February 2021) provides an overview of policies and services for people with autism spectrum disorder in England.
Children and young people’s mental health
Eighth Report of Session 2021–22
Health and Social Care Committee
30 November 2021
HC 17
Second Special Report of Session 2021–22
Health and Social Care Committee
30 November 2021
HC 612
Chapter 2 covers the committee’s findings on children and young people’s mental health commitment ratings.
The most recent Children’s Commissioner annual report on the state of children’s mental health services (published 28 January 2021) provides further background on this subject.
New, synthetic versions of harmful drugs, including synthetic opioids and synthetic cannabinoids, are increasingly found in UK’s illegal drug markets.
An overview of the current system of support for children and young people with special educational needs, and pressure on the system. Updated with new 2024-25 SEND incidence and EHC plan data
This briefing focuses on two disease-modifying dementia drugs that are currently being appraised by the National Institute for Health and Care Excellence (NICE): lecanemab and donanemab